Pathophysiology and classification of primary graft dysfunction after lung transplantation

Area of Science:

• Pulmonology
• Transplantation Medicine
• Immunology

Background:

• Primary graft dysfunction (PGD) is a spectrum of acute lung injury (ALI) occurring within 72 hours of lung transplantation.
• PGD significantly hinders early post-transplant outcomes and increases the risk of subsequent bronchiolitis obliterans syndrome (BOS).
• Histologically, PGD involves diffuse alveolar damage, clinically graded by PaO2/FiO2 ratio and radiographic infiltrates.

Purpose of the Study:

• To review the current clinical status of primary graft dysfunction (PGD).
• To discuss the pathophysiology of PGD, including its multifactorial etiology.
• To explore current therapies and future directions for PGD clinical management.

Main Methods:

• Review of current clinical status and literature on PGD.
• Discussion of PGD pathophysiology, focusing on ischemia-reperfusion injury (IRI) and immune cell involvement.
• Analysis of factors contributing to PGD, including donor, recipient, and operative elements.

Main Results:

• PGD is a major obstacle to successful lung transplantation.
• Ischemia-reperfusion injury (IRI), mediated by tissue-resident macrophages and subsequent neutrophil/lymphocyte influx, is a common cause of PGD.
• Donor history, recipient health, and operative factors influence PGD development.

Conclusions:

• PGD significantly impacts lung transplant outcomes and long-term graft survival.
• Minimizing PGD incidence is an ongoing research priority.
• Emerging techniques like ex vivo lung perfusion show promise in mitigating PGD.